San Carlos, Calif.
Went public on 7/19/2000 at $15 per share
Filing Range: 4 mil. shares @ $13 to $15
Shares Outstanding: 16.4 mil. shares
Underwriters: UBS Warburg/ING Barings/SG Cowen
Company Counsel: Wilson Sonsini Goodrich & Rosati
Manager Counsel: Dewey Ballantine LLP
Auditor: Ernst & Young LLP
Develops instruments, reagents and consumable products for use in medicinal chemistry. The company’s products apply solid-phase technology to the synthesis and purification of small organic molecules. Solid-phase synthesis utilizes polymeric resins as a means for manipulating molecules during their synthesis and purification.
Schroder Ventures International Life Sciences
Kleiner Perkins Caufield & Byers
Institutional Venture Partners
Robertson Stephens & Co. LLC
Integral Capital Partners
Number of Round Amt.
Round # Round Date Stage Investors ($ thousands)
1 01/13/1995 3 Early Stage 4500.0
2 04/23/1996 5 Expansion 9500.0
3 01/01/1997 1 Expansion 736.0
4 06/21/1999 7 Expansion 14999.8
(Data in $ millions)
Total Revenues: $10.6
Net Income: -7.6